Diagnostic Approach for Acute Alcoholic Hepatitis

Clinical Diagnostic Criteria

• The American Association for the Study of Liver Diseases recommends a diagnosis of acute alcoholic hepatitis using a combination of clinical features, laboratory findings, and in selected cases, liver biopsy confirmation, with the diagnosis classification ranging from definite to probable or possible based on specific criteria 1, 2
• History of heavy alcohol consumption is defined as >40g/day for women and >50-60g/day for men, typically for >6 months with <60 days of abstinence before jaundice onset, according to the American Association for the Study of Liver Diseases 1, 3
• Rapid onset of jaundice, defined as serum bilirubin >3 mg/dL, is a key clinical feature, as recommended by the European Association for the Study of the Liver 1, 4
• Tender hepatomegaly on physical examination is a common finding, as noted by the American Association for the Study of Liver Diseases 1, 5

Laboratory Findings

• Elevated AST (>50 IU/mL) with AST/ALT ratio >1.5 is a characteristic laboratory pattern, according to the American Association for the Study of Liver Diseases 1, 5
• AST and ALT typically do not exceed 400 IU/mL, distinguishing from drug-induced or ischemic liver injury, as recommended by the American Association for the Study of Liver Diseases 1, 3
• Elevated serum bilirubin (>3 mg/dL) is a common laboratory finding, as noted by the European Association for the Study of the Liver 1, 4

Diagnostic Classification

• Definite alcoholic hepatitis is diagnosed by clinical diagnosis plus liver biopsy confirmation, with histologic features including macrovesicular steatosis plus at least one of the following: neutrophil infiltration, hepatocyte ballooning, or Mallory-Denk bodies, as recommended by the American Association for the Study of Liver Diseases 1, 6
• Probable alcoholic hepatitis is diagnosed by clinical diagnosis with typical presentation and laboratory findings, without confounding factors, as noted by the American Association for the Study of Liver Diseases 1, 6

Severity Assessment

• The Maddrey Discriminant Function (MDF) is used to define severe alcoholic hepatitis, with a score ≥32 indicating severe disease, as recommended by the American Association for the Study of Liver Diseases 1, 7
• The MELD score is also used to assess disease severity, with a score >20 indicating severe disease, as noted by the American Association for the Study of Liver Diseases 1, 7

Special Considerations

• The transjugular route is preferred for liver biopsy due to frequent coagulation disorders or ascites, as recommended by the European Association for the Study of the Liver 8, 7
• Even "moderate" alcoholic hepatitis (MDF <32) carries significant mortality, with 10% at 6 months and 20% at 1 year, as noted by the European Association for the Study of the Liver 8, 7

Alcoholic Hepatitis Management

Clinical Assessment and Scoring

• The American Association for the Study of Liver Diseases recommends calculating Maddrey's score in patients with suspected alcoholic hepatitis who present with jaundice and a history of heavy alcohol use, as this score is essential for identifying severe disease requiring immediate treatment 9, 10
• Patients with fever and leukocytosis may have severe alcoholic hepatitis, and this presentation warrants further evaluation 11
• The European Association for the Study of the Liver suggests that a Maddrey score ≥32 defines severe alcoholic hepatitis and mandates consideration of corticosteroid therapy, with a significant mortality risk without treatment 9, 10, 12, 13

Prognostic Scoring Systems

• The American College of Gastroenterology recommends calculating the MELD score alongside Maddrey's score, as it provides additional prognostic information, with a MELD score >20-21 indicating severe disease with high 90-day mortality risk 9, 10, 12, 13
• The MELD score incorporates creatinine, making it particularly useful for identifying renal dysfunction 12, 13
• The Lille score should be calculated on day 7 after initiating treatment to identify treatment responders, with a Lille score ≥0.45 indicating non-responders and a score ≥0.56 indicating null responders 9, 10

Risk Stratification and Management

• Patients with a Maddrey score <32 still require close monitoring and aggressive supportive care, including nutritional therapy and alcohol abstinence counseling, due to substantial mortality risk 9, 10
• Combined static (Maddrey/MELD at baseline) and dynamic (Lille at day 7) prognostication should be used for optimal risk stratification, rather than relying solely on Maddrey's score 9, 10, 12, 13

Diagnostic Criteria for Acute Alcohol‑Associated Hepatitis

Laboratory Diagnostic Markers

• An AST/ALT ratio > 2 is characteristic of alcohol‑associated hepatitis and reflects pyridoxal‑phosphate deficiency and mitochondrial injury that preferentially releases AST. 14
• The typical biochemical pattern includes AST levels 2–6 × the upper limit of normal (but usually < 400 IU/L) together with a serum bilirubin concentration > 3 mg/dL, which defines the jaundice that is the principal presenting feature. 14
• Neutrophilia is frequently present alongside the AST/ALT > 1.5 (often > 2) and bilirubin > 3 mg/dL pattern. [14][15]
• Relying solely on clinical and laboratory criteria carries a 10–50 % risk of misclassifying patients; therefore, when uncertainty exists, a transjugular liver biopsy may be warranted. 14

Role of Imaging

• Abdominal ultrasound may show non‑specific findings such as fatty infiltration and hepatomegaly, which cannot differentiate alcohol‑associated hepatitis from other liver diseases; imaging is therefore a supportive, not diagnostic, tool. 15

Prognostic Scores vs. Diagnostic Tools

• Maddrey’s Discriminant Function (DF ≥ 32) and the Model for End‑Stage Liver Disease (MELD) score are prognostic instruments that stratify disease severity and guide therapy (e.g., corticosteroids) but do not establish the diagnosis of alcohol‑associated hepatitis. [14][15]
• INR and serum albumin reflect hepatic synthetic function and disease severity but lack diagnostic specificity because abnormalities occur in many acute and chronic liver conditions. [14][15]

Additional Clinical Considerations

• The diagnostic algorithm requires integration of a heavy alcohol consumption history (≈ 40–60 g/day for > 6 months with < 60 days abstinence before jaundice onset) with the characteristic laboratory pattern and exclusion of alternative etiologies (viral hepatitis, autoimmune hepatitis, drug‑induced injury, Wilson disease, biliary obstruction). (derived from article context; no specific citation)

Management of Severe Alcoholic Hepatitis with Decompensation

1. Criteria for Immediate Hospital Admission

• A middle‑aged adult with decompensated alcoholic hepatitis, critically low serum potassium (≈ 2.9 mEq/L) and severe hypomagnesemia (≈ 1.2 mg/dL) who is receiving loop diuretics should be transferred directly to the emergency department for inpatient admission. 16, 17

2. Diagnostic Evaluation of Alcoholic Hepatitis

• Serum bilirubin ≈ 5.7 mg/dL together with AST ≈ 228 U/L, ALT ≈ 72 U/L and an AST/ALT ratio > 1.5 fulfills the standard laboratory criteria for alcoholic hepatitis. 16
• All patients presenting with jaundice and suspected alcoholic hepatitis should be admitted to allow alcohol abstinence, nutritional optimization, infection exclusion, and close clinical monitoring. 16

3. Severity Stratification and Treatment Eligibility

• The Maddrey Discriminant Function (mDF) and Model for End‑Stage Liver Disease (MELD) score must be calculated on admission; severe disease is defined as mDF ≥ 32 or MELD > 20, which triggers consideration of corticosteroid therapy. 16, 17
• In the absence of treatment and with continued alcohol use, 90‑day mortality for severe alcoholic hepatitis ranges from 40 % to 50 %. 16, 18
• When mDF ≥ 32 or MELD > 20 and no contraindications exist (e.g., active infection, gastrointestinal bleeding, renal failure with creatinine > 2.5 mg/dL), initiate prednisolone 40 mg orally once daily for 28 days. 16
• On day 7 of corticosteroid therapy, calculate the Lille score; discontinue steroids if Lille ≥ 0.45, indicating non‑response. 19

4. Mandatory Infection Screening Before Any Immunosuppression

• Blood cultures, urine cultures, and diagnostic paracentesis (if ascites is present) must be obtained immediately on admission, regardless of fever, because infection is present in 20‑30 % of cases and is the principal trigger for multi‑organ failure. 16, 19
• Active infection is an absolute contraindication to corticosteroid initiation and must be definitively excluded before therapy. 19

5. Electrolyte Management and Diuretic Use

• Loop diuretics (e.g., furosemide) should be avoided or used only sparingly in patients with alcoholic hepatitis, as they can precipitate acute kidney injury and worsen outcomes. 16, 17
• Furosemide must be stopped immediately until serum electrolytes are corrected and volume status reassessed. 17, 18

6. Nutritional Support and Alcohol Abstinence

• Initiate aggressive nutritional support delivering 30‑40 kcal/kg/day and 1.0‑1.5 g protein/kg/day; malnutrition is nearly universal in severe alcoholic hepatitis and correlates with poorer prognosis. 18
• Enforced absolute alcohol abstinence during hospitalization is the single most important intervention for long‑term survival. 17, 18

7. Assessment for Spontaneous Bacterial Peritonitis (SBP)

• In any patient with ascites and suspected alcoholic hepatitis, perform diagnostic paracentesis with cell count, culture, and albumin measurement to rule out SBP before starting corticosteroids. 16

8. Operational Pitfalls to Avoid

• Do not delay inpatient admission while awaiting specialty referral; immediate emergency department evaluation is required. 16
• Do not commence corticosteroids without first excluding infection, given its high prevalence and impact on mortality. 16, 19